Michael Kamarck, PhD, is Chief Technology Officer at Vir. Vir integrates recent innovations in science, technology and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-modality approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses.
Vir’s initial focus is in three areas of significant unmet need: chronic infectious diseases including hepatitis B, tuberculosis and HIV; respiratory disease, including influenza, RSV, MPV; and the identification of host-...Read more
The international ME-conference is the premier conference for the field bringing together leading experts, scientists, and students from industry, the government and academia to present and discuss cutting edge research.
